Oncolytics Biotech (ONCY) Tops Q3 EPS by 1c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Isabella Bank added to Russell 2000 index after Nasdaq listing
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM